9.1 Hypertensive Disorders of Pregnancy & Preeclampsia Management
Key Takeaways
Hypertensive disorders of pregnancy are categorized into four core entities: chronic hypertension (pre-dating pregnancy or diagnosed before 20 weeks), gestational hypertension (new onset BP >=140/90 after 20 weeks without proteinuria), preeclampsia-eclampsia, and chronic hypertension with superimposed preeclampsia.
Preeclampsia diagnosis requires new-onset hypertension (>=140/90 mmHg on two occasions at least 4 hours apart) after 20 weeks gestation plus proteinuria (>=300 mg/24-hour urine, UPCR >=0.3, or dipstick 2+), OR in the absence of proteinuria, any new severe feature.
Severe features include systolic BP >=160 or diastolic BP >=110 mmHg, thrombocytopenia (platelets <100,000/mcL), impaired liver function (AST/ALT >2x normal) or severe persistent RUQ/epigastric pain, progressive renal insufficiency (serum creatinine >1.1 mg/dL or doubling), pulmonary edema, or new visual/cerebral disturbances.
Seizure prophylaxis requires magnesium sulfate (4–6 g IV loading dose over 20–30 minutes, followed by 1–2 g/hr continuous infusion); therapeutic range is 4.8–8.4 mg/dL (4–7 mEq/L), monitored via patellar reflexes, respiratory rate (>=12/min), and urine output (>=30 mL/hr), with calcium gluconate 1 g IV ready for toxicity reversal.
Acute severe hypertension (BP >=160/110 mmHg) is a hypertensive emergency requiring intervention within 30–60 minutes using IV labetalol, IV hydralazine, or oral immediate-release nifedipine, while low-dose aspirin 81 mg daily, started at 12–28 weeks and ideally before 16 weeks, is the U.S. standard for preeclampsia prevention in at-risk patients.
Classification of Hypertensive Disorders in Pregnancy
Hypertensive disorders of pregnancy encompass a spectrum of vascular and multisystem pathologies. Precise classification dictates maternal-fetal surveillance, pharmacologic thresholds, and timing of delivery.
1. Chronic Hypertension
- Diagnostic Criteria: Blood pressure (BP) ≥140 mmHg systolic and/or ≥90 mmHg diastolic that pre-dates pregnancy, is diagnosed before 20 weeks gestation, or persists longer than 12 weeks postpartum.
- Clinical Significance: Carries a 20% to 25% risk of developing superimposed preeclampsia, intrauterine fetal growth restriction (FGR), and placental abruption.
2. Gestational Hypertension
- Diagnostic Criteria: New-onset systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg documented on two occasions at least 4 hours apart after 20 weeks gestation in a previously normotensive patient, in the absence of proteinuria or systemic end-organ dysfunction.
- Clinical Course: Blood pressure normalizes before 12 weeks postpartum (confirming transient gestational hypertension). If hypertension persists beyond 12 weeks postpartum, the diagnosis is reclassified as chronic hypertension. Up to 50% of women presenting with gestational hypertension eventually develop preeclampsia features.
3. Preeclampsia Without Severe Features
- Diagnostic Criteria: New-onset hypertension (systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg on two occasions at least 4 hours apart after 20 weeks) PLUS proteinuria.
- Proteinuria Definitions:
- ≥300 mg per 24-hour urine collection (gold standard).
- Urine protein-to-creatinine ratio (UPCR) ≥0.3 mg/mg.
- Urine dipstick protein reading of 2+ (utilized only when quantitative methods are unavailable).
4. Preeclampsia With Severe Features
Diagnosed when preeclampsia exhibits systolic BP ≥160 mmHg or diastolic BP ≥110 mmHg on two occasions at least 4 hours apart (sooner if antihypertensive therapy has been started), OR any of the following new-onset systemic manifestations develops (even in the complete absence of proteinuria):
- Thrombocytopenia: Platelet count <100,000/mcL.
- Impaired Liver Function: Serum transaminases (AST or ALT) elevated to greater than twice the upper limit of normal, or severe persistent right upper quadrant or epigastric pain unresponsive to medication and not accounted for by alternative diagnoses.
- Progressive Renal Insufficiency: Serum creatinine >1.1 mg/dL or a doubling of baseline serum creatinine concentration in the absence of pre-existing renal disease.
- Pulmonary Edema: Clinical dyspnea, hypoxemia, rales, and radiographic pulmonary congestion.
- New-Onset Visual or Cerebral Disturbances: Intractable, severe throbbing headache unresponsive to analgesics, scotomata, photopsia, cortical blindness, or altered mental status.
Important
Under current clinical practice standards, massive proteinuria (>5 g/24 hours) and fetal growth restriction (FGR) are no longer classified as standalone severe features that mandate immediate preterm delivery. However, close antenatal fetal surveillance remains paramount when FGR is present.
5. Chronic Hypertension With Superimposed Preeclampsia
Diagnosed in a woman with pre-existing chronic hypertension who develops new-onset proteinuria after 20 weeks gestation, a sudden refractory acceleration in blood pressure, or any of the systemic severe features (thrombocytopenia, transaminitis, renal impairment, pulmonary edema, or neurological symptoms).
6. Eclampsia
- Definition: The onset of new generalized tonic-clonic seizures in a pregnant or postpartum patient with preeclampsia that cannot be attributed to other neurologic causes (e.g., epilepsy, intracranial hemorrhage, infection, or metabolic derangement).
- Timing: Approximately 50% of eclamptic events occur antepartum, 25% intrapartum, and 25% postpartum (most within the first 48 hours, though late postpartum eclampsia can occur up to 6 weeks postpartum).
7. HELLP Syndrome
A severe variant of preeclampsia characterized by microvascular endothelial activation, fibrin deposition, platelet consumption, and hepatic microvascular ischemia:
- H (Hemolysis): Microangiopathic hemolytic anemia with peripheral smear schistocytes, elevated total bilirubin (≥1.2 mg/dL), low serum haptoglobin, and lactate dehydrogenase (LDH >600 IU/L).
- EL (Elevated Liver Enzymes): Serum AST or ALT ≥2 times the upper limit of normal.
- LP (Low Platelets): Platelet count <100,000/mcL.
| Hypertensive Disorder | Onset Window | BP Threshold (mmHg) | Proteinuria Required? | Hallmark Features |
|---|---|---|---|---|
| Chronic Hypertension | <20 weeks or pre-pregnancy | ≥140/90 | No | Persists >12 weeks postpartum |
| Gestational Hypertension | >20 weeks gestation | ≥140/90 | No | No end-organ damage; normalizes postpartum |
| Preeclampsia (without severe) | >20 weeks gestation | ≥140/90 | Yes (or end-organ) | Proteinuria ≥300 mg/24h or UPCR ≥0.3 |
| Preeclampsia (with severe) | >20 weeks gestation | ≥160/110 OR severe feature | No | Platelets <100k, transaminitis, Cr >1.1, neuro symptoms |
| Eclampsia | Antepartum, intrapartum, postpartum | Variable | Variable | New generalized tonic-clonic seizures |
| HELLP Syndrome | >20 weeks or postpartum | Variable | Variable | Hemolysis (LDH >600), AST/ALT >2x, Platelets <100k |
Pharmacotherapy: Seizure Prophylaxis with Magnesium Sulfate
Magnesium sulfate is the definitive, first-line agent for the prevention and treatment of eclamptic seizures. It functions via central nervous system vasodilation, protection of the blood-brain barrier against hydrostatic edema, and competitive antagonism of N-methyl-D-aspartate (NMDA) receptor channels.
Dosing Regimen
- Loading Dose: 4 to 6 grams IV diluted in 100 mL normal saline or D5W administered over 20 to 30 minutes.
- Maintenance Infusion: 1 to 2 grams per hour continuous IV infusion, maintained throughout labor and continued for 24 hours postpartum or 24 hours after the last seizure.
- Therapeutic Serum Level: 4.8 to 8.4 mg/dL (equivalent to 4.0 to 7.0 mEq/L).
Clinical Monitoring Protocol
Because magnesium is excreted entirely by the kidneys, patients must undergo rigorous, frequent bedside assessments:
- Deep Tendon Reflexes (DTRs): Patellar reflexes must be present. Loss of DTRs is the earliest clinical sign of hypermagnesemia, occurring at levels of 9 to 12 mg/dL (7.5–10 mEq/L).
- Respiratory Rate: Must be ≥12 breaths per minute. Respiratory depression occurs at levels of 12 to 15 mg/dL (10–12.5 mEq/L).
- Urinary Output: Must be maintained at ≥30 mL/hour (or ≥100 mL over 4 hours). If renal output drops, magnesium rapidly accumulates, precipitating toxicity.
- Cardiac Conduction Deficits & Arrest: Occur at serum concentrations >15 to 20 mg/dL.
Management of Magnesium Toxicity
If hyporeflexia, respiratory depression, or altered sensorium occurs:
- Immediately discontinue the magnesium sulfate infusion.
- Administer Calcium Gluconate: 1 gram IV push (10 mL of a 10% solution) slowly over 2 to 3 minutes.
- Provide supplemental oxygen and secure the airway if respiratory failure is imminent.
Note
In patients with renal insufficiency (serum creatinine >1.1 mg/dL), administer the standard 4 g loading dose, but reduce the maintenance infusion to 1 g/hour (or monitor serial serum magnesium concentrations every 4 to 6 hours, adjusting the rate accordingly).
Acute Severe Antihypertensive Protocols
Acute-onset, sustained severe hypertension (systolic BP ≥160 mmHg and/or diastolic BP ≥110 mmHg lasting ≥15 minutes) in pregnancy or the puerperium represents a hypertensive emergency. The primary objective is to prevent maternal intracranial hemorrhage, encephalopathy, and cardiovascular collapse. Emergency antihypertensive pharmacotherapy must be initiated within 30 to 60 minutes.
| Agent | Initial Dose | Escalation & Dosing Interval | Clinical Pearls & Contraindications |
|---|---|---|---|
| IV Labetalol | 20 mg IV bolus over 2 minutes | If BP remains ≥160/110 at 10 min, give 40 mg IV; if still elevated at 20 min, give 80 mg IV; then 80 mg IV at 30 min (Max: 220–300 mg total). | Combined alpha- and beta-blocker. Contraindicated in active asthma, severe sinus bradycardia, heart block >first degree, and decompensated heart failure. |
| IV Hydralazine | 5 to 10 mg IV bolus over 2 minutes | If BP remains ≥160/110 at 20 min, administer 10 mg IV; repeat q20 min as needed (Max: 20–30 mg total). | Direct peripheral arteriolar vasodilator. May induce reflex tachycardia, maternal hypotension, and fetal heart rate decelerations. |
| Oral Nifedipine | 10 to 20 mg PO immediate-release | If BP remains ≥160/110 at 20–30 min, administer 20 mg PO; repeat q20–30 min as needed (Max: 180 mg/day). | Calcium channel blocker. Excellent oral alternative when IV access is not yet established. Do not administer sublingually (precipitates unpredictable profound hypotension). |
Preeclampsia Prevention & Delivery Timing
Prevention with Low-Dose Aspirin
- Mechanism: Selectively inhibits platelet cyclooxygenase-1 (COX-1), restoring the balance between prothrombotic thromboxane A2 and vasodilatory prostacyclin, promoting physiological trophoblastic invasion.
- Dosing & Initiation: 81 mg daily in U.S. guidance (ACOG Committee Opinion 743; USPSTF 2021), started at 12–28 weeks (optimally before 16 weeks) and continued until delivery. Some international guidelines use about 150–162 mg.
- Indications:
- High Risk (≥1 factor): Prior pregnancy complicated by preeclampsia, chronic hypertension, pregestational type 1 or type 2 diabetes, chronic renal disease, autoimmune disease (systemic lupus erythematosus, antiphospholipid syndrome), or multifetal gestation.
- Moderate Risk (≥2 factors): Nulliparity, obesity (pre-pregnancy BMI >30 kg/m²), family history of preeclampsia, advanced maternal age (≥35 years), sociodemographic characteristics, or personal history factors (low birth weight, prior adverse outcome).
Standardized Delivery Timing
Definitive treatment for preeclampsia is delivery of the fetus and placenta. Timing is calibrated to balance maternal systemic risks against neonatal prematurity:
- Gestational Hypertension or Preeclampsia WITHOUT Severe Features: Planned delivery at 37 0/7 weeks gestation.
- Preeclampsia WITH Severe Features: Delivery at 34 0/7 weeks gestation after stabilization. Expectant management between 24 0/7 and 33 6/7 weeks is considered only at tertiary centers in stable maternal-fetal conditions.
- Immediate Delivery (Regardless of Gestational Age): Mandated for maternal instability: refractory acute severe hypertension, eclamptic seizures, pulmonary edema, placental abruption, disseminated intravascular coagulation (DIC), progressive renal failure, or non-reassuring fetal status.
A 31-year-old primigravida at 34 weeks 2 days gestation presents to obstetric triage reporting an intractable frontotemporal headache and epigastric discomfort over the past 6 hours. Her blood pressure is 168/114 mmHg, confirmed on repeat measurement 15 minutes later. Physical examination reveals 3+ patellar deep tendon reflexes and mild right upper quadrant tenderness without peritoneal signs. Transabdominal fetal monitoring demonstrates a reactive fetal heart rate tracing without decelerations. Laboratory results reveal: platelets 88,000/mcL, AST 142 U/L, ALT 136 U/L, and serum creatinine 1.2 mg/dL. Which pharmacologic regimen represents the most urgent, appropriate initial management?
Administer oral labetalol 100 mg twice daily and schedule betamethasone with planned discharge home for outpatient bed rest.
IV magnesium sulfate 4–6 g load, then 1–2 g/hr, plus IV labetalol 20 mg for the severe-range blood pressure.
Administer IV hydralazine 20 mg IV push immediately followed by oral nifedipine 30 mg extended-release.
Initiate an IV oxytocin infusion for immediate vaginal delivery without antihypertensive therapy until active labor is established.
A 26-year-old G2P1 at 32 weeks gestation is admitted to the labor and delivery unit for inpatient expectant management of preeclampsia with severe features. She is receiving continuous IV magnesium sulfate at 2 g/hour for neuroprotection and seizure prophylaxis. During a routine nursing assessment 4 hours into therapy, the patient appears drowsy. Her patellar deep tendon reflexes are completely absent bilaterally, her respiratory rate is 9 breaths per minute, and her indwelling Foley catheter has collected 18 mL of urine over the last 2 hours. What is the immediate, life-saving clinical action?
Increase intravenous maintenance fluids to 200 mL/hour to flush excess magnesium through the renal tubules.
Draw a stat serum magnesium level and decrease the magnesium sulfate maintenance infusion rate to 0.5 g/hour.
Immediately stop the magnesium sulfate infusion and administer calcium gluconate 1 g IV slowly over 2 to 3 minutes.
Administer naloxone 0.4 mg IV push and place the patient in the left lateral decubitus position.
A 29-year-old primigravida presents for her initial prenatal visit at 13 weeks gestation. Her medical history is notable for pregestational type 1 diabetes mellitus diagnosed at age 14 and chronic hypertension treated with oral labetalol 200 mg twice daily. Her blood pressure today is 128/82 mmHg. Urinalysis demonstrates trace protein. When counseling this patient on evidence-based strategies to minimize her risk of developing preeclampsia, which recommendation is most appropriate?
Initiate low-dose aspirin (81 mg daily) now and continue it daily until delivery.
Discontinue labetalol immediately to prevent fetal intrauterine growth restriction and avoid all prophylactic medications.
Prescribe supplemental high-dose vitamin C (1,000 mg) and vitamin E (400 IU) daily starting at 20 weeks gestation.
Place the patient on strict bed rest and sodium restriction of less than 1,500 mg per day throughout the remainder of pregnancy.
Sections you finish are checked off in the contents.